Physician compensation is rising faster in cardiology than any other specialty. Still, considering how demanding the job is, many cardiologists feel underpaid.
Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.
Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNA
Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis.
Performing TAVR on a patient with bicuspid AS can be challenging. Transcatheter aortic root tricuspidization may represent a new treatment strategy for these patients, according to a new first-in-human trial.
Stroke is still a leading cause of death all over the world. A new AI model showed early potential to anticipate such adverse outcomes up to a decade in advance, ensuring high-risk patients receive the care they need.
Image courtesy of Shockwave Medical, part of Johnson & Johnson MedTech.
The Shockwave C2 Aero Coronary IVL Catheter is based on years of user feedback. For example, it was built with improved deliverability and repositioning capabilities in mind.
Up to 30% of U.S. patients carry genetic variations that reduce the effectiveness of clopidogrel, an antiplatelet medication sold under the brand name Plavix.
When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business.